Letter to the Editor

Opsoclonus, limbic encephalitis, anti-Ma2 antibodies and gastric adenocarcinoma

  1. D. Biotti1,2,*,
  2. A. Viaccoz3,
  3. N. Olivier1,2,
  4. C. Tilikete1,2,
  5. V. Rogemond3,
  6. J. Honnorat2,3,
  7. A. Vighetto1,2

Article first published online: 17 NOV 2012

DOI: 10.1111/j.1468-1331.2012.03881.x

Issue

European Journal of Neurology

European Journal of Neurology

Volume 19, Issue 12, pages e144–e145, December 2012

Additional Information

How to Cite

Biotti, D., Viaccoz, A., Olivier, N., Tilikete, C., Rogemond, V., Honnorat, J. and Vighetto, A. (2012), Opsoclonus, limbic encephalitis, anti-Ma2 antibodies and gastric adenocarcinoma. European Journal of Neurology, 19: e144–e145. doi: 10.1111/j.1468-1331.2012.03881.x

Author Information

  1. 1

    Neurology and Neuro-ophthalmology Departments, Hospices Civils de Lyon, Neurological Hospital, Bron

  2. 2

    Université de Lyon 1 – Université Claude Bernard, Lyon, France

  3. 3

    Centre de Référence Maladies Rares ‘Syndromes Neurologiques Paranéoplastiques’, Hospices Civils de Lyon, Neurological Hospital, Bron, France

*Correspondence: Dr Damien Biotti, Unité 402 – Hôpital neurologique, 59 Boulevard Pinel, 69394 Lyon, France (tel.:+33472357882; fax:+33472357351; e-mail: damien.biotti@chu-lyon.fr).

Publication History

  1. Issue published online: 17 NOV 2012
  2. Article first published online: 17 NOV 2012
  3. Manuscript Accepted: 21 AUG 2012
  4. Manuscript Received: 27 JUN 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (525K)
FilenameFormatSizeDescription
ene3881-sup-0001-VideoS1.wmvvideo/wmv7026KVideo S1. Opsoclonus.

Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

View Full Article with Supporting Information (HTML) Get PDF (525K)